Promoter collection, Human MET promoter
Alternative name | U2872-10 |
---|---|
Clone info. | PCR amplified human MET promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 116670988 to 116672444(NC_000007.14); relatively -1208 to +249, where +1 corresponds to 1 nt of NM_001127500.3. |
Comment | PCR cloning, forward primer: CCTGCAAAATGGTTCAATGCAA; reverse primer: CTGCTCACAAAGCGCTCGG. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human met proto-oncogene (hepatocyte growth factor receptor) genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07554.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07554 | pGL4-phMET | DNA solution |
Materials & Methods section:
The pGL4-phMET was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07554). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07554_A3Hc.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB07554_A3Hca.seq |
---|
>07554_07554_A3Hc_pGL4-4174F_G03_21.ab1 1 GCTTGGGGCA GAAATTTCTC TGGCCTACTG GCCGGTACCT GAGCTCGCTA GCCTCGAGGA 61 TCCTGCAAAA TGGTTCAATG CAAGACTTTA GTAACGTAAT GGGAACTTTC CTTTTCCATA 121 AAACTGGGGA ATCAAGAGGT AATCTCTTTT GAGGACTGAA ATCACTCTTA TGTAACCTCT 181 GGTTACATTA TCATTTCCAA GTGCCTGGCA CTTGGGAAAT GATAACTATT CTTACTACAT 241 TTTTCTATGT TTCATTCTGT AGTAAATAAG AACTGAACCT GCATAGTAAC TGTTATTTTA 301 ACCCATGACT TTCAATAACG AAGATATCTA TGTCTCATTA TCTATTGCCA TGATTGAACA 361 AGTTGGTATG AGAGCCGGAA CGAACTCAAG TTCTAACCGG CAATGCCCGT TCCTTAGATC 421 CTATTACCTT TGAGTGTTCA TTTACTCTTG TAGGTGCCAA TTTTTATAGC GAAATACAAA 481 GTTATCCCAA CACAATTACT CCTAATAGAG TTCACCGAGG CCCCAAAAGC TCTTTTTTTA 541 AAATCATCAT AAGATTTCAA CATTCAAGAA TTAAACTTTT GTTCTGTTGT GCTTATTCAT 601 CGCTATTTGC CCAGTTATTT AATCAGCCTG CTTCCGGCTA TGGAAAAAAA AAAAAAGAAA 661 AAAAGAAATG GAAGTCTCCT CAGGGTTAAA CTCCTCTGTT GTTCTTCCTT GCAGAAATTT 721 GAGTTATTAT AGTAGAGGAT AATCGTTGCA TAATGAAATC ATTGGGACAA TTCGTCCATC 781 CACTTCTACC TCCGCCTCTA ACAATGAACT CCTTGTTTCT GCGGTGCCCA AATCTCTCTA 841 AACCCGGGTG GGCGCGGGGC GGTTAGCGGA GACGTGGGAG AGGCCGAGAG CAAAGCTCGC 901 GCCCTTCCCG GGGTCAGCGA GCGGGGGTGC CAGGAGGGTG CGCGCCCTGC CTCTGAGCCC 961 GGGGTGACAC TCGCCTCCAA GCGCCAGGAG GGGGAGACTC GGGTCCCGCT TATCTCCGGC 1021 TGTGCTAACT TCAGACTGCC TGAGCTGGGG GGAGGGAGAG CCGCGGCAGC CCAGGGCGAG 1081 AAAAACTTTC TCCAACTTAG AAGTTCACTT GCTCGTGGGC GGGGCAGAAA GGTCGGGGAA 1141 GGTAA // |
Primer: Sequence file: RDB07554_A3Hcb.seq |
>07554_07554_A3Hc_pGL4-136R_H03_24.ab1 1 GCGCTTTGGG TTTTTGGGAT CTTCCATGGT GGCTTTACGA ACAGTACCGG GATTGCCAAG 61 CTTGGCCGCC GAGGCCAGAT CTTGATCTGC TCACAAAGCG CTCGGGGCGC CGCGGGCGGC 121 GAGGGCCTCC GGGTCACCTG CGGCCGGGCT GAGCCCAGCG CCCCGCCCGC CCGCCGGCCG 181 CACTCCCTCC GCCCCTTCCC ACACGCGCGC TGCCCTGCCA GTGACTCAGC CGGGCATCGG 241 CGCGCGCGGC CCGCGGCGGC CCGGGCGCGT TGGGGCCGGA GGCACCGCCA GGCGACCAGA 301 CTGAGGCGCT CGCCTGCCCG CCCCAGCACG TGTCTGTCTG CCTCGCGTGC TGTCCGTCCC 361 CTAGTCCGCG GGTTCCGAGG ACCGCTGAGG TGGGGACTGG CACCACCCAG AGGGAAATCG 421 GCCCCCGCCC TTCCTGCCGT CCGCGCCGCG CCTGGCCCCG CGGGGGTCGC GTTTCCTCCC 481 GCCTCTGCCC CGCCCACGAC AAGGTGAAAC TTTCTAGGTG GAGAAGTTTT CTCGCCCTGG 541 CTGCGCGCTC TCCTCCCCCA GCTCAGGCAG TCTGAAGTTA GCACAGCCGG AGATAAGCGG 601 GACCGAGTCT CCCCCTCCTG GCGCTTGGGA GGCGAGTGTC ACCCCGGGCT CAGAGGCAGG 661 GCGCGCACCC TCCTGGCACC CCGCTCGCTG ACCCCGGGAA GGGCGCGAGC TTTGCTCTCG 721 GCCTCTCCCA CGTCTCCGCT AACCGCCCCG CGCCCACCCG GGTTTAGAGA GATTTGGGCA 781 CCGCAGAAAC AAGGAGTTCA TTGTTAGAGG CGGAGGTAGA AAGTGGATGG ACGAATTGTC 841 CCAATGATTT CATTATGCAA ACGATTATCC TCTACTATAA TAACTCAAAT TTCTGCAAGG 901 AAGAACAAAC AGAGGAGTTT AACCCCTGAG GAGACTTCCA TTTTCTTTTT TTTTCTTTTT 961 TTTTTTTTTT TTCCCATAGC CGGGAAGCAG GGCTTGAATT AAAATAAACT TGGGGCAAAA 1021 TAGCCGAATG AATAAAGCAA CCACACAAGA AACAAAAAAG GTTTTAAATT TCTCTTTGAA 1081 ATGGTTGGAA AATCCTTTAT AGGAATGATT TTTTAAAAAA AGAGAAGCCT TTTTTGGGGG 1141 TCTTCCGGTG GAAACCTCTA ATTAAGGGAG ACTAAAATTT GGGGTGGTTT GGGGGAGAAT 1201 ACACACTCT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content